Christian Wolf (C Wolf)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Neurology(R) neuroimmunology & neuroinflammation

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Fox, Heinz Wiendl, Christian Wolf, Nicola De Stefano, Johann Sellner, Viktoriia Gryb, Konrad Rejdak, Plamen S Bozhinov, Daniel Vitt, Hella Kohlhof, Jason Slizgi, Matej Ondrus, Valentina Sciacca, Andreas R Muehler, null null
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Robert J Fox, Heinz Wiendl, Christian Wolf, Nicola De Stefano, Johann Sellner, Viktoriia Gryb, Konrad Rejdak, Plamen S Bozhinov, Daniel Vitt, Hella Kohlhof, Jason Slizgi, Matej Ondrus, Valentina Sciacca, Andreas R Muehler, null null
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Robert J Fox, Heinz Wiendl, Christian Wolf, Nicola De Stefano, Johann Sellner, Viktoriia Gryb, Konrad Rejdak, Plamen S Bozhinov, Daniel Vitt, Hella Kohlhof, Jason Slizgi, Matej Ondrus, Valentina Sciacca, Andreas R Muehler, null null
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Robert J Fox, Heinz Wiendl, Christian Wolf, Nicola De Stefano, Johann Sellner, Viktoriia Gryb, Konrad Rejdak, Plamen S Bozhinov, Daniel Vitt, Hella Kohlhof, Jason Slizgi, Matej Ondrus, Valentina Sciacca, Andreas R Muehler, null null
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Wallace J Brownlee, Christian Wolf, Hans-Peter Hartung, Theo Dingermann, Nadia Anshasi, Richard Ac Clark, Maria Trojano, Krzysztof Selmaj, Bernard Mj Uitdehaag, Carmen Tur, Jens Wuerfel, Gabriele Dallmann, Julian Witte, Martina Sintzel, Olga Bobrovnikova, Jeffrey A Cohen
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (14) (2022)
Tobias Derfuss, Jaume Sastre-Garriga, X Montalban, M Rodegher, J Wuerfel, Laura Gaetano, D Tomic, A Azmon, Christian Wolf, Ludwig Kappos
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 6 (1) (2020)
Bruce Ac Cree, Baldur Magnusson, Nicolas Rouyrre, Robert J Fox, Gavin Giovannoni, Patrick Vermersch, Amit Bar-Or, Ralf Gold, Daniela Piani Meier, Göril Karlsson, Davorka Tomic, Christian Wolf, Frank Dahlke, Ludwig Kappos
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (10) (2020)
Ralph H B Benedict, Davorka Tomic, Bruce A Cree, Robert Fox, Gavin Giovannoni, Amit Bar-Or, Ralf Gold, Patrick Vermersch, Harald Pohlmann, Ian Wright, Göril Karlsson, Frank Dahlke, Christian Wolf, Ludwig Kappos
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses. Neurology 96 (3) (2020)
Randi Hagerman, Sebastien Jacquemont, Elizabeth Berry-Kravis, Vincent Des Portes, Andrew Stanfield, Barbara Koumaras, Gerd Rosenkranz, Alessandra Murgia, Christian Wolf, George Apostol, Florian von Raison
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents. Scientific reports 8 (1) (2018)

Christian Wolf.css-eqlu8i{font-size:small;padding-left:4px;} (C Wolf)

Publication Activity (10 Years)

Top Topics

Top Venues

Christian Wolf (C Wolf)